Bard’s LifeStent Gets Legs: PMA Approved For Femoral, Popliteal Arteries
This article was originally published in The Gray Sheet
Executive Summary
C.R. Bard is now able to market its LifeStent for treating occluded leg arteries with a PMA approval announced Feb. 17